News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ocular Therapeutix, Inc. To Present New Data On Sustained Release Drug Candidates Utilizing Proprietary Hydrogel Technology At The Association for Research in Vision & Ophthalmology Annual Meeting


4/28/2014 9:13:14 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Ocular Therapeutix, Inc. , which is developing sustained release ophthalmic drug products using a proprietary hydrogel technology, has announced six posters will be presented at the upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting in taking place at the Orange County Convention Center in Orlando, Florida, from May 4-8, 2014.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES